| Followers | 96 |
| Posts | 5080 |
| Boards Moderated | 0 |
| Alias Born | 02/07/2021 |
Tuesday, April 11, 2023 8:48:50 PM
Northwest Biotherapeutics management delivered what no other firm has been able to achieve. They developed the platform for all solid tumors as well as Fordist manufacturing processes to scale up for global demand. This means being able to access hundreds of billions in global sales. If realized that translates to a trillion dollar market cap.
I can wait a month or two for that possible outcome. I can wait a couple of years in fact. I will never sell my NWBO shares. If some are so impatient then perhaps they shouldn't be invested in this company. An FDIC-backed CD at 5% might be their cup of tea.
For those others:
Buy Now Or Cry Later!
https://jamanetwork.com/journals/jamaoncology/fullarticle/2798847
https://www.researchsquare.com/article/rs-2591941/v1
https://nwbio.com/glioblastoma-drug-development-summit/
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=169815671
I can wait a month or two for that possible outcome. I can wait a couple of years in fact. I will never sell my NWBO shares. If some are so impatient then perhaps they shouldn't be invested in this company. An FDIC-backed CD at 5% might be their cup of tea.
For those others:
Buy Now Or Cry Later!
https://jamanetwork.com/journals/jamaoncology/fullarticle/2798847
https://www.researchsquare.com/article/rs-2591941/v1
https://nwbio.com/glioblastoma-drug-development-summit/
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=169815671
Bullish
Do your own research. I am not providing legal or investment advice. This is an anonymous forum for entertainment purposes only. Don't trust anything you read.
Recent NWBO News
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/26/2025 05:15:34 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
